Author

M. A. Wallet

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

L. H. Armitage· 3 shared C. E. Mathews· 2 shared D. Egli· 2 shared J. P. Taylor· 2 shared A. M. Meacham· 1 shared A. Savinov· 1 shared B. N. Newby· 1 shared D. J. Perry· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

L. H. Armitage

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 Diabetes

L. H. Armitage, S. E. Stimpson, K. E. Santostefano, L. Sui, S. O. Ogundare, B. N. Newby, R. Castro-Gutierrez, M. K. Huber, J. P. Taylor, P. Sharma, I. Radichev, D. J. Perry, N. Fredette, A. Savinov, N. Terada, , C. E. Mathews

This paper demonstrates the use of induced pluripotent stem cells to create an isogenic system for studying genetic influences on cell-cell interactions in type 1 diabetes.

bioRxiv · May 3, 2021Immunology

High-Yield Monocyte, Macrophage, and Dendritic Cell Differentiation from Induced Pluripotent Stem Cells

L. H. Armitage, M. Khosravi Maharlooei, A. M. Meacham, E. J. Butfiloski, R. M. Viola, D. Egli, M. Sykes, M. A. Wallet, C. E. Mathews

This paper describes a highly efficient method to differentiate iPSC into monocytes, MDMs, and moDCs with high purity and yield, overcoming previous limitations in culture efficiency and scalability.

bioRxiv · Apr 29, 2021 · PreprintImmunology

Harmine enhances the activity of the HIV-1 latency-reversing agents ingenol A and SAHA

J. P. Taylor, L. H. Armitage, D. L. Aldridge, M. N. Cash, M. A. Wallet

This study shows that harmine enhances the efficacy of HIV-1 latency-reversing agents by increasing transcription factor availability and reducing HEXIM1 expression.

bioRxiv · Jan 31, 2020Microbiology